by Rishabh Mishra | Mar 2, 2026 | General
Toll Brothers Inc. (NYSE:TOL) is capturing investor attention as its fundamental valuation strengthens alongside robust quarterly performance. TOL Value Score Rises The company’s value score on the Benzinga Edge’s Stock Rankings dashboard rose from 89.55 to...
by Namrata Sen | Mar 2, 2026 | General
Piper Sandler has revised its rating for cybersecurity firm CrowdStrike Holdings (NASDAQ:CRWD), identifying artificial intelligence (AI) as a significant growth catalyst rather than a threat. Analyst Rob Owens upgraded CrowdStrike from neutral to overweight and also...
by Avi Kapoor | Mar 2, 2026 | General
U.S. stock futures were lower this morning, with the Dow futures falling around 1% on Monday. Shares of Yatsen Holding Ltd – ADR (NYSE:YSG) fell sharply in pre-market trading after reporting fourth-quarter results. Yatsen Holding posted adjusted earnings of 7 cents...
by Avi Kapoor | Mar 2, 2026 | General
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. RBC Capital analyst Brian Abrahams downgraded Aardvark...
by Vandana Singh | Mar 2, 2026 | General
Ascendis Pharma A/S (NASDAQ:ASND) shares are up during Monday’s premarket session following the FDA’s approval of Yuviwel (navepegritide; developed as TransCon CNP), the first and only once-weekly treatment for children with achondroplasia. FDA Approval The FDA...
Recent Comments